Laurel Wealth Advisors (California)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,168
Closed -$255K 666
2022
Q3
$255K Sell
1,168
-38
-3% -$8.65K 0.03% 535
2022
Q2
$253K Sell
1,206
-1,097
-48% -$234K 0.03% 552
2022
Q1
$559K Hold
2,303
0.05% 380
2021
Q4
$600K Buy
+2,303
New +$598K 0.05% 386

Other funds holding RMD

Laurel Wealth Advisors (California)'s RMD Position: Q4 2022 in Review

Laurel Wealth Advisors (California) sold out of ResMed (RMD) in Q4 2022, closing a stake of 1,168 shares — an estimated $255K sold.

Laurel Wealth Advisors (California) first reported a position in RMD in Q4 2021 and held it in 4 quarters. The position peaked at $600K in Q4 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Laurel Wealth Advisors (California) reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 1,168 ResMed shares in Q4 2022, an estimated $255K.
  • Laurel Wealth Advisors (California) first reported a position in ResMed in Q4 2021 and held it in 4 quarters.
  • Laurel Wealth Advisors (California)'s ResMed position peaked at $600K in Q4 2021.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.